Source: UNIVERSITY OF ILLINOIS submitted to NRP
USE OF AN EXOGENOUS L-LACTATE CLEARANCE TEST IN HORSES WITH ACUTE GASTROINTESITNAL DISEASE AS AN AID TO IMPROVING PROVISION OF CARE AND EVALUATING SHORT-TERM PROGNOSIS
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1002405
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Jan 20, 2014
Project End Date
Sep 30, 2014
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
UNIVERSITY OF ILLINOIS
2001 S. Lincoln Ave.
URBANA,IL 61801
Performing Department
Veterinary Research & Extension
Non Technical Summary
Single or serial measurement of blood L-lactate concentration ([LAC]) is considered a reliable prognostic indicator in sick adult horses, particularly those with GI diseases. Various estimates of endogenous [LAC] increase/decrease over time used in recent studies in humans, foals and adult horses suggest that these measures of endogenous [LAC] change over time (D [LAC]) may be more useful than single measurements. Surviving adult horses with primary GI problems (large colon volvulus and colitis) presenting on an emergency basis have significantly lower [LAC] at all sampling times; however, proportional [LAC] changes with time only became significantly different (with non-survivors having negative D[LAC]) after 48 hours of treatment, suggesting continued or new depressed clearance and/or increased production in non-survivors. Serial monitoring of [LAC] in horses with colitis indicated that survival is associated with a greater proportional D[LAC] from admission to both 8 and 24 hours of treatment. Calculation of 'true clearance' (the volume of blood or plasma per unit time from which the compound of interest is removed) of exogenously administered LAC (ExLC) in hemodynamically stable septic human patients has been shown a useful prognostic indicator. The technique allows for determination of both LAC production and clearance and has potential utility in interrogating the underlying processes of hyperlactemia in critically ill veterinary patients. An equine species-specific ExLC test should provide more precise monitoring and prognostic information and improve patient care and outcome.
Animal Health Component
50%
Research Effort Categories
Basic
30%
Applied
50%
Developmental
20%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31138101020100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3810 - Horses, ponies, and mules;

Field Of Science
1020 - Physiology;
Goals / Objectives
Specific, Testable Hypotheses and Objectives:Hypothesis 1: Horses with acute GI disease and moderate to severe hyperlactemia at presentation will have lower ClLAC following volume resuscitation than those with normal [LAC] or mild hyperlactemia at presentation.Specific aim: To measure ClLAC in horses with acute GI disease using an equine specific ExLC test and determine if it is different in horses with various [LAC] at presentation.Hypothesis 2: ClLAC will be lower in volume resuscitated non-surviving horses with acute GI disease when compared to survivors.Specific aim: To measure ClLAC in horses with acute GI disease using an equine specific ExLC test and determine if it is associated with survival to discharge.Hypothesis 3: ClLAC and other pharmacokinetic (PK) parameters will be similar when calculated using either a desktop LAC analyzer or handheld POC LAC analyzer.Specific aim: To assess the agreement of a hand-held POC LAC measuring device with a table top device in determining ClLAC and other PK parameters associated with an ExLC test in horses.
Project Methods
Animals: Approximately 30 adult (greater than 2 years of age) client-owned horses presenting to the veterinary teaching hospital with complaints associated with the GI tract. Horses must require hospitalization and fluid resuscitation as a component of treatment as determined by the admitting clinician. Horses euthanized at admission due to financial constraints or euthanized during or immediately following surgery will not be included in the study.L-lactate infusion and sample collection: Once fluid/volume resuscitation is considered adequate the horse will undergo ExLC under the supervision of one of the clinical co-investigators as previously described. Samples will be analyzed using a YSI LAC measuring table top device ([LAC]YSI) previously validated for use in the horse within 30 minutes of collection. Immediately prior to LAC infusion a 14 ga catheter will be placed using sterile technique in a jugular vein -not used for volume resuscitation- for sample collection during the sodium LAC infusion and post-infusion periods. A sterile sodium LAC solution (500 ml containing 1 mmol/kg body weight Na lactate) will be infused intravenously via the catheter in the opposite jugular vein over 15 minutes at a constant rate by use of a fluid pump. Five ml volume blood samples for [LAC] determination will be collected from the first jugular catheter after sterile presampling (10 ml) and placed in evacuated sodium citrate glass tubes immediately prior to infusion, and at 5, 10 and 15 minutes of sodium LAC infusion. Presample blood collected under sterile conditions will be returned to the horse prior to next sample and the catheter flushed with sterile 0.9% saline in order to reduce blood loss from the patient. Additional blood samples will be similarly collected at 1 minute intervals for 15 minutes post-infusion and 30, 45, 60 minutes post-infusion and then hourly until LAC returns to baseline values.Data analysis: The modeling software WinSAAM 3.0.7 will be used for modeling and PK analyses. Population average estimates of model parameters and their errors will be determined for each group. PK parameters will be compared between groups using appropriate statistical methods (T-test, Mann-Whitney U) depending on the distribution of the data.

Progress 01/20/14 to 09/30/14

Outputs
Target Audience: An abstract of the results of this study was published in the Journal of Veterinary Emergency and Critical Care in association with presentation of the results in an oral abstract presentation at the International Veterinary Emergency and Critical Care Society meeting in Indianapolis, Indianain September of 2014. Changes/Problems: Although we gathered sufficient data to check agreement between the analyzers the tabletop analyzer broke beyond repair to be of further use, so we have continued the study using only the handheld monitor. Most horses enrolled in the study have survived, limiting our ability to evaluate the test as a prognositic indicator. Instead, we have moved to using a simpler test that we are evaluating in a separate study. The study of clearance remains a very valuable study in that it is allowing us to query the underlying causes of persistent hyperlactatemia in horses with acute GI disease. What opportunities for training and professional development has the project provided? This project has provided research training opportunities for 1 resident in Emergency and Critical Care and 1 resident/graduate student in Equine Internal Medicine. Veterinary students have participated in the project if a study was ongoing while they were on the equine medicine service. How have the results been disseminated to communities of interest? Results were disseminated asresearch abstract presentations and will also be disseminsted as a research manuscript in a peer-reviewed journal once all data are fully analyzed. What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? Thirty adult horses presenting for acute gastrointestinal disease and requiring fluid resuscitation had been planned for study. To date, eight horses have been enrolled. Horses were fluid resuscitated prior to entering the study. Sodium L-lactate solution (1.0 mmol/kg IV) was administered over 15 minutes and L-lactate concentration [LAC] measured immediately prior to, during, and post infusion. Disposition modeling will beperformed using proprietary software once data from all horses has beencollected.All eight horses survived. Four horses were explored surgically and lesions corrected while four horses were treated medically. Four horses were mildly hyperlactemic ([LAC]>1.2 mmol/L) at the time of study; mean [LAC] immediately prior to infusion was 1.2 mmol/L (range 0.7–1.8). [LAC] at end-infusion was 2.55 mmol/L (range 1.6–3.7) with a mean increase of 1.3 mmol/L (range 0.9–2.1). Time to return to baseline was 251 min (range 45–555) and may be prolonged in medical (345 min) vs. surgical (158 min) disease (P = 0.087). Conclusion: Infusion of exogenous L-lactate 1.0 mmol/kg BW provides sufficient increase in [LAC] for future disposition modeling. We have completed analysis on 20 of the 30 horses to date, medically treated horses (horses with medically amenable problems) show slower clearance than do horses treated surgically. There has been insufficient number of horses that did not survive to evaluate any association with prognosis. The tabletop and handheld measuring devices provide concordant but predictablydifferent results

Publications

  • Type: Conference Papers and Presentations Status: Published Year Published: 2014 Citation: Vander Werf, K., Wilkins, P.A., Sheahan, B. and Boston, R.C. Exogenous L-lactate clearance in horses with gastrointestinal disease. Journal of Veterinary Emergency and Critical Care 2014;24(S1):S2.